Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04082234 · ClinicalTrials.gov registry record · NA
Reducing Disparities in Behavioral Health Treatment for Children in Primary Care
A NA study of ADHD, sponsored by Children's Hospital of Philadelphia.
- Active
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT04082234: Active NA study of ADHD, sponsored by Children's Hospital of Philadelphia.
NCT04082234 is a NA study of ADHD that is active but no longer recruiting, run by Children's Hospital of Philadelphia. The registered enrollment target is 300 participants, above the 186-participant average among 75 other ADHD trials with a reported enrollment target (61% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04082234, a NA study of ADHD, is active but no longer recruiting, sponsored by Children's Hospital of Philadelphia.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to address a decisional dilemma faced by health system officials, policy makers, and clinical leaders: "Does it make sense to integrate behavior therapy into primary care practice to treat children with ADHD from low-income settings? More specifically, does integrated care improve access to services and patient-centered outcomes for underserved children with ADHD?" Participants will be randomly assigned to one of two groups: Behavior therapy integrated into primary care (Partnering to Achieve School Success; PASS program) to treatment as usual (TAU) informed by American Academy of Pediatrics (AAP) guidelines for ADHD practice and facilitated by electronic practice supports." Participants will be 300 children (ages 5-11) with ADHD and their caregivers served at Children's Hospital of Philadelphia Care Network Locations (primary care offices). Participants are drawn from primary care locations that serve primarily low-income and racial/ethnic minority population.
Primary Outcome
The Inattention/Task Avoidance factor of the Homework Problem Checklist (HPC) will be used as a parent-report measure of academic performance. This 12-item scale has strong psychometric properties and is responsive to family-school intervention programs.
Conditions Studied
Interventions
- OTHER Treatment as Usual (TAU)
- BEHAVIORAL Partnering to Achieve School Success (PASS)
Study Locations (1)
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2019-11-01 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
What the registry record for NCT04082234 still lists
NCT04082234 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, above the 186-participant average among 75 other ADHD trials with a reported enrollment target (61% higher).
The record links to 1 condition, with ADHD appearing as the primary indexed condition, and to 2 interventions - of which Treatment as Usual (TAU) is the first listed.
NCT04082234 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04082234 about?
NCT04082234 is a clinical study titled "Reducing Disparities in Behavioral Health Treatment for Children in Primary Care". The purpose of this study is to address a decisional dilemma faced by health system officials, policy makers, and clinical leaders: "Does it make sense to integrate behavior therapy into primary care practice to treat children with ADHD from low-income settings? More specifically, does integrated ca...
What is the current status of trial NCT04082234?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2019-11-01. Estimated completion is 2026-03-31.
What conditions does trial NCT04082234 study?
This clinical trial studies the following conditions: ADHD.
What interventions are being tested in trial NCT04082234?
The interventions under investigation include: Treatment as Usual (TAU) (OTHER), Partnering to Achieve School Success (PASS) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04082234?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04082234 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ADHD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04082234's enrollment target sits among peer trials
300 10th of 75 higher than 66 of 75 other ADHD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other ADHD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)
RECRUITING · NA
-
Target ADHD Executive Working Memory Replication Study
RECRUITING · NA
-
Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)
RECRUITING · NA
-
Fidgeting and Attentional and Emotional Regulation in ADHD
RECRUITING · NA
-
Moms Managing Attention-Deficit/Hyperactivity Disorder (ADHD) Study
RECRUITING · NA
-
A Pilot Study of a Remote ADHD Monitoring Program
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI